Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Machado-Joseph-Azorean disease. A ten-year study.

H L Fowler

    Archives of Neurology
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Machado-Joseph-Azorean disease (MJAD) presents with three distinct syndromes, offering better functional deficit descriptions. Researchers observed novel neuronal degeneration patterns and seek biologic markers for genetic counseling.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II--a family study.

    Clinical genetics·1992
    Same author

    Rotator cuff tears. A shoulder arthroscopy complication.

    The American journal of sports medicine·1989
    Same author

    Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis.

    The New England journal of medicine·1989
    Same author

    Unstable femoral shaft fractures: a comparison of interlocking nailing versus traction and casting methods.

    Journal of orthopaedic trauma·1988
    Same author

    Stokes-Adams attacks masquerading as epilepsy: case reports.

    Military medicine·1984
    Same author

    Joseph disease in non-Portuguese.

    Neurology·1984
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Area of Science:

    • Neurology
    • Genetics
    • Clinical Medicine

    Background:

    • Machado-Joseph-Azorean disease (MJAD) is a progressive neurodegenerative disorder.
    • Previous classifications of MJAD syndromes lacked detailed functional deficit descriptions.
    • Understanding MJAD's progression is crucial for early diagnosis and genetic counseling.

    Purpose of the Study:

    • To identify and describe distinct clinical syndromes within Machado-Joseph-Azorean disease.
    • To investigate the patterns of neuronal degeneration in MJAD patients.
    • To explore potential biologic markers for improved genetic counseling.

    Main Methods:

    • A ten-year longitudinal study involving patients with Machado-Joseph-Azorean disease.
    • Clinical classification based on observed functional deficits.

    Related Experiment Videos

  • Neuropathological examination to identify patterns of neuronal degeneration.

    • Main Results:

    • Three distinct MJAD syndromes were identified: ataxia, ataxia-motor neuron-extrapyramidal, and a mixed form.
    • Novel patterns of neuronal degeneration were observed, spreading from the cerebellum to motor neurons and the extrapyramidal system.
    • Peripheral neuropathy was a late complication, and dementia was absent in all patients.

    Conclusions:

    • The identified syndromes provide a more accurate description of functional deficits in MJAD.
    • The study reveals new insights into the neuropathological spread of MJAD.
    • Electronystagmography changes may serve as a useful biologic marker for genetic counseling in MJAD.